Join Now

Category Archives: BioUtah News

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

By Natalie Themm | Published February 8, 2024

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

| Tagged | Comments Off on Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech Technology to Advance the Clinical Development of Novel Therapeutics Targeting Neuroinflammation

By Natalie Themm | Published February 8, 2024

This technology will support the development of Halia’s new Alzheimer’s disease drug, HT-4253, targeting a mediator of neuroinflammation called Leucine-rich repeat kinase 2 (LRRK2)

| Tagged | Comments Off on Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech Technology to Advance the Clinical Development of Novel Therapeutics Targeting Neuroinflammation

AdvaMed Announces New Chair of State Medtech Alliance

By Natalie Themm | Published February 8, 2024

AdvaMed Announces New Chair of State Medtech Alliance

| Tagged | Comments Off on AdvaMed Announces New Chair of State Medtech Alliance

AI Utah Annouces Inaugural AI Utah 100 List

By Natalie Themm | Published February 1, 2024

AI Utah Annouces Inaugural AI Utah 100 List

| Tagged | Comments Off on AI Utah Annouces Inaugural AI Utah 100 List

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

By Natalie Themm | Published February 1, 2024

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

| Tagged | Comments Off on Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

By Natalie Themm | Published February 1, 2024

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

| Tagged | Comments Off on Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

Utah Innovation Fund invests $700k in local healthcare, life sciences startups

By Natalie Themm | Published February 1, 2024

Utah Innovation Fund invests $700k in local healthcare, life sciences startups

| Tagged | Comments Off on Utah Innovation Fund invests $700k in local healthcare, life sciences startups

BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing

By Natalie Themm | Published February 1, 2024

AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions

| Tagged | Comments Off on BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing

Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

By Natalie Themm | Published February 1, 2024

SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology, effective March 18, 2024. Dr. Daneker brings more than 30 years of oncology and precision medicine […]

| Tagged | Comments Off on Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

By Natalie Themm | Published February 1, 2024

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

| Tagged | Comments Off on bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

By Natalie Themm | Published February 1, 2024

Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

| Tagged | Comments Off on Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery

ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration

By Natalie Themm | Published January 25, 2024

ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration

| Tagged | Comments Off on ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration

A Special Thanks To Our Legacy and Platinum Elite Members